Healthcare • Diagnostics & Research
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PRPO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 10
17 filers reported a long position in PRPO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1M | 46.1K | +81.1% |
| BlackRock, Inc. | $858.1K | 34.7K | +19.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $462.9K | 18.7K | -0.6% |
| RENAISSANCE TECHNOLOGIES LLC | $401.1K | 16.2K | -16.1% |
| CITADEL ADVISORS LLC | $364.3K | 14.7K | -2.7% |
| XTX Topco Ltd | $234K | 9.5K | New |
| VANGUARD FIDUCIARY TRUST CO | $232.9K | 9.4K | +0.7% |
| DIMENSIONAL FUND ADVISORS LP | $207.9K | 8.4K | New |
| UBS Group AG | $8.5K | 343 | +51.1% |
| WELLS FARGO & COMPANY/MN | $1.2K | 50 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.